Article Text

Download PDFPDF
Extended report
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammation
  1. Jan Piet van Hamburg1,2,
  2. Patrick S Asmawidjaja1,2,
  3. Nadine Davelaar1,2,
  4. Adriana M C Mus1,2,
  5. Ferry Cornelissen1,2,
  6. Johannes P T M van Leeuwen3,
  7. Johanna M W Hazes1,
  8. Radboud J E M Dolhain1,
  9. Pieter A G M Bakx4,
  10. Edgar M Colin1,5,
  11. Erik Lubberts1,2
  1. 1Department of Rheumatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
  2. 2Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
  3. 3Department of Internal Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
  4. 4Department of Orthopedics, Maasstad Hospital, Rotterdam, The Netherlands
  5. 5Department of Rheumatology, ZGT, Almelo, The Netherlands
  1. Correspondence to Erik Lubberts, Departments of Rheumatology and Immunology, Erasmus MC, University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands; e.lubberts{at}erasmusmc.nl

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Medical ethics committee of the Erasmus MC, Rotterdam, The Netherlands.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval Medical ethics committee of the Erasmus MC, Rotterdam, The Netherlands.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.